| A bipartite structural organization defines the SERINC family of HIV-1 restriction factors VE Pye, A Rosa, C Bertelli, WB Struwe, SL Maslen, R Corey, I Liko, ... Nature structural & molecular biology 27 (1), 78-83, 2020 | 61 | 2020 |
| SERINC5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus C Firrito, C Bertelli, T Vanzo, A Chande, M Pizzato Annual Review of Virology 5, 323-340, 2018 | 44 | 2018 |
| Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine A Grandi, M Tomasi, I Ullah, C Bertelli, T Vanzo, S Accordini, A Gagliardi, ... Vaccines 11 (10), 1546, 2023 | 6 | 2023 |
| HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial … C Urbinati, M Milanesi, N Lauro, C Bertelli, G David, P D’Ursi, M Rusnati, ... Molecules 26 (24), 7488, 2021 | 6 | 2021 |
| A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation C Firrito, C Bertelli, A Rosa, A Chande, S Ananth, H van Dijk, OT Fackler, ... Viruses 15 (3), 652, 2023 | 1 | 2023 |
| Viral particles imaging through evanescent wave scattering in a total internal reflection laser microscope RL Savio, S Piselli, C Bertelli, M Pizzato, A Carloni Sensing and Bio-Sensing Research 37, 100517, 2022 | 1 | 2022 |
| Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample G Barbieri, M Pizzato, M Gögele, D Giardiello, CX Weichenberger, L Foco, ... BMJ open 13 (6), e072650, 2023 | | 2023 |
| Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine (preprint) A Grandi, M Tomasi, I Ullah, C Bertelli, T Vanzo, S Accordini, A Gagliardi, ... | | 2023 |
| Antiviral activity and retroviral counteraction of SERINC genes C Bertelli Università degli studi di Trento, 2021 | | 2021 |
| Antiviral activity and retroviral counteraction of SERINC genes M Pizzato, C Bertelli | | |
